Global Anti-inflammatory Biologics Market Research Report 2023

Report ID: 2010814 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Anti-inflammatory Biologics Market Overview
    1.1 Product Overview and Scope of Anti-inflammatory Biologics
    1.2 Anti-inflammatory Biologics Segment by Type
        1.2.1 Global Anti-inflammatory Biologics Market Value Comparison by Type (2023-2029)
        1.2.2 Synthetic Type
        1.2.3 Biological Type
    1.3 Anti-inflammatory Biologics Segment by Application
        1.3.1 Global Anti-inflammatory Biologics Market Value by Application: (2023-2029)
        1.3.2 Arthritis
        1.3.3 Respiratory Diseases
        1.3.4 Dermatology
        1.3.5 Gastroenterology
        1.3.6 Others
    1.4 Global Anti-inflammatory Biologics Market Size Estimates and Forecasts
        1.4.1 Global Anti-inflammatory Biologics Revenue 2018-2029
        1.4.2 Global Anti-inflammatory Biologics Sales 2018-2029
        1.4.3 Global Anti-inflammatory Biologics Market Average Price (2018-2029)
    1.5 Assumptions and Limitations
2 Anti-inflammatory Biologics Market Competition by Manufacturers
    2.1 Global Anti-inflammatory Biologics Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Anti-inflammatory Biologics Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Anti-inflammatory Biologics Average Price by Manufacturers (2018-2023)
    2.4 Global Anti-inflammatory Biologics Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Anti-inflammatory Biologics, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Anti-inflammatory Biologics, Product Type & Application
    2.7 Anti-inflammatory Biologics Market Competitive Situation and Trends
        2.7.1 Anti-inflammatory Biologics Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Anti-inflammatory Biologics Players Market Share by Revenue
        2.7.3 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-inflammatory Biologics Retrospective Market Scenario by Region
    3.1 Global Anti-inflammatory Biologics Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Anti-inflammatory Biologics Global Anti-inflammatory Biologics Sales by Region: 2018-2029
        3.2.1 Global Anti-inflammatory Biologics Sales by Region: 2018-2023
        3.2.2 Global Anti-inflammatory Biologics Sales by Region: 2024-2029
    3.3 Global Anti-inflammatory Biologics Global Anti-inflammatory Biologics Revenue by Region: 2018-2029
        3.3.1 Global Anti-inflammatory Biologics Revenue by Region: 2018-2023
        3.3.2 Global Anti-inflammatory Biologics Revenue by Region: 2024-2029
    3.4 North America Anti-inflammatory Biologics Market Facts & Figures by Country
        3.4.1 North America Anti-inflammatory Biologics Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Anti-inflammatory Biologics Sales by Country (2018-2029)
        3.4.3 North America Anti-inflammatory Biologics Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Anti-inflammatory Biologics Market Facts & Figures by Country
        3.5.1 Europe Anti-inflammatory Biologics Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Anti-inflammatory Biologics Sales by Country (2018-2029)
        3.5.3 Europe Anti-inflammatory Biologics Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Anti-inflammatory Biologics Market Facts & Figures by Country
        3.6.1 Asia Pacific Anti-inflammatory Biologics Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Anti-inflammatory Biologics Sales by Country (2018-2029)
        3.6.3 Asia Pacific Anti-inflammatory Biologics Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Anti-inflammatory Biologics Market Facts & Figures by Country
        3.7.1 Latin America Anti-inflammatory Biologics Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Anti-inflammatory Biologics Sales by Country (2018-2029)
        3.7.3 Latin America Anti-inflammatory Biologics Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Anti-inflammatory Biologics Market Facts & Figures by Country
        3.8.1 Middle East and Africa Anti-inflammatory Biologics Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Anti-inflammatory Biologics Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E
4 Segment by Type
    4.1 Global Anti-inflammatory Biologics Sales by Type (2018-2029)
        4.1.1 Global Anti-inflammatory Biologics Sales by Type (2018-2023)
        4.1.2 Global Anti-inflammatory Biologics Sales by Type (2024-2029)
        4.1.3 Global Anti-inflammatory Biologics Sales Market Share by Type (2018-2029)
    4.2 Global Anti-inflammatory Biologics Revenue by Type (2018-2029)
        4.2.1 Global Anti-inflammatory Biologics Revenue by Type (2018-2023)
        4.2.2 Global Anti-inflammatory Biologics Revenue by Type (2024-2029)
        4.2.3 Global Anti-inflammatory Biologics Revenue Market Share by Type (2018-2029)
    4.3 Global Anti-inflammatory Biologics Price by Type (2018-2029)
5 Segment by Application
    5.1 Global Anti-inflammatory Biologics Sales by Application (2018-2029)
        5.1.1 Global Anti-inflammatory Biologics Sales by Application (2018-2023)
        5.1.2 Global Anti-inflammatory Biologics Sales by Application (2024-2029)
        5.1.3 Global Anti-inflammatory Biologics Sales Market Share by Application (2018-2029)
    5.2 Global Anti-inflammatory Biologics Revenue by Application (2018-2029)
        5.2.1 Global Anti-inflammatory Biologics Revenue by Application (2018-2023)
        5.2.2 Global Anti-inflammatory Biologics Revenue by Application (2024-2029)
        5.2.3 Global Anti-inflammatory Biologics Revenue Market Share by Application (2018-2029)
    5.3 Global Anti-inflammatory Biologics Price by Application (2018-2029)
6 Key Companies Profiled
    6.1 AbbVie
        6.1.1 AbbVie Corporation Information
        6.1.2 AbbVie Description and Business Overview
        6.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 AbbVie Anti-inflammatory Biologics Product Portfolio
        6.1.5 AbbVie Recent Developments/Updates
    6.2 Johnson & Johnson
        6.2.1 Johnson & Johnson Corporation Information
        6.2.2 Johnson & Johnson Description and Business Overview
        6.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Johnson & Johnson Anti-inflammatory Biologics Product Portfolio
        6.2.5 Johnson & Johnson Recent Developments/Updates
    6.3 Amgen Inc
        6.3.1 Amgen Inc Corporation Information
        6.3.2 Amgen Inc Description and Business Overview
        6.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Amgen Inc Anti-inflammatory Biologics Product Portfolio
        6.3.5 Amgen Inc Recent Developments/Updates
    6.4 AstraZeneca PLC
        6.4.1 AstraZeneca PLC Corporation Information
        6.4.2 AstraZeneca PLC Description and Business Overview
        6.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 AstraZeneca PLC Anti-inflammatory Biologics Product Portfolio
        6.4.5 AstraZeneca PLC Recent Developments/Updates
    6.5 Pfizer, Inc
        6.5.1 Pfizer, Inc Corporation Information
        6.5.2 Pfizer, Inc Description and Business Overview
        6.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Pfizer, Inc Anti-inflammatory Biologics Product Portfolio
        6.5.5 Pfizer, Inc Recent Developments/Updates
    6.6 Novartis
        6.6.1 Novartis Corporation Information
        6.6.2 Novartis Description and Business Overview
        6.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Novartis Anti-inflammatory Biologics Product Portfolio
        6.6.5 Novartis Recent Developments/Updates
    6.7 Roche
        6.6.1 Roche Corporation Information
        6.6.2 Roche Description and Business Overview
        6.6.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Roche Anti-inflammatory Biologics Product Portfolio
        6.7.5 Roche Recent Developments/Updates
    6.8 Sun Pharmaceutical Industries Ltd
        6.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
        6.8.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
        6.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product Portfolio
        6.8.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
    6.9 Sanofi
        6.9.1 Sanofi Corporation Information
        6.9.2 Sanofi Description and Business Overview
        6.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Sanofi Anti-inflammatory Biologics Product Portfolio
        6.9.5 Sanofi Recent Developments/Updates
    6.10 GlaxoSmithKline
        6.10.1 GlaxoSmithKline Corporation Information
        6.10.2 GlaxoSmithKline Description and Business Overview
        6.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 GlaxoSmithKline Anti-inflammatory Biologics Product Portfolio
        6.10.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Anti-inflammatory Biologics Industry Chain Analysis
    7.2 Anti-inflammatory Biologics Key Raw Materials
       7.2.1 Key Raw Materials
       7.2.2 Raw Materials Key Suppliers
    7.3 Anti-inflammatory Biologics Production Mode & Process
    7.4 Anti-inflammatory Biologics Sales and Marketing
        7.4.1 Anti-inflammatory Biologics Sales Channels
        7.4.2 Anti-inflammatory Biologics Distributors
    7.5 Anti-inflammatory Biologics Customers
8 Anti-inflammatory Biologics Market Dynamics
    8.1 Anti-inflammatory Biologics Industry Trends
    8.2 Anti-inflammatory Biologics Market Drivers
    8.3 Anti-inflammatory Biologics Market Challenges
    8.4 Anti-inflammatory Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

List of Tables
    Table 1. Global Anti-inflammatory Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Anti-inflammatory Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Anti-inflammatory Biologics Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Anti-inflammatory Biologics Sales (K MT) of Key Manufacturers (2018-2023)
    Table 5. Global Anti-inflammatory Biologics Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Anti-inflammatory Biologics Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Anti-inflammatory Biologics Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Anti-inflammatory Biologics Average Price (USD/MT) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Anti-inflammatory Biologics, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Anti-inflammatory Biologics, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Anti-inflammatory Biologics, Product Type & Application
    Table 12. Global Key Manufacturers of Anti-inflammatory Biologics, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Biologics as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anti-inflammatory Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Anti-inflammatory Biologics Sales by Region (2018-2023) & (K MT)
    Table 18. Global Anti-inflammatory Biologics Sales Market Share by Region (2018-2023)
    Table 19. Global Anti-inflammatory Biologics Sales by Region (2024-2029) & (K MT)
    Table 20. Global Anti-inflammatory Biologics Sales Market Share by Region (2024-2029)
    Table 21. Global Anti-inflammatory Biologics Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Anti-inflammatory Biologics Revenue Market Share by Region (2018-2023)
    Table 23. Global Anti-inflammatory Biologics Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Anti-inflammatory Biologics Revenue Market Share by Region (2024-2029)
    Table 25. North America Anti-inflammatory Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Anti-inflammatory Biologics Sales by Country (2018-2023) & (K MT)
    Table 27. North America Anti-inflammatory Biologics Sales by Country (2024-2029) & (K MT)
    Table 28. North America Anti-inflammatory Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Anti-inflammatory Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Anti-inflammatory Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Anti-inflammatory Biologics Sales by Country (2018-2023) & (K MT)
    Table 32. Europe Anti-inflammatory Biologics Sales by Country (2024-2029) & (K MT)
    Table 33. Europe Anti-inflammatory Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Anti-inflammatory Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Anti-inflammatory Biologics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Anti-inflammatory Biologics Sales by Region (2018-2023) & (K MT)
    Table 37. Asia Pacific Anti-inflammatory Biologics Sales by Region (2024-2029) & (K MT)
    Table 38. Asia Pacific Anti-inflammatory Biologics Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Anti-inflammatory Biologics Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Anti-inflammatory Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Anti-inflammatory Biologics Sales by Country (2018-2023) & (K MT)
    Table 42. Latin America Anti-inflammatory Biologics Sales by Country (2024-2029) & (K MT)
    Table 43. Latin America Anti-inflammatory Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Anti-inflammatory Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Anti-inflammatory Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Anti-inflammatory Biologics Sales by Country (2018-2023) & (K MT)
    Table 47. Middle East & Africa Anti-inflammatory Biologics Sales by Country (2024-2029) & (K MT)
    Table 48. Middle East & Africa Anti-inflammatory Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Anti-inflammatory Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Anti-inflammatory Biologics Sales (K MT) by Type (2018-2023)
    Table 51. Global Anti-inflammatory Biologics Sales (K MT) by Type (2024-2029)
    Table 52. Global Anti-inflammatory Biologics Sales Market Share by Type (2018-2023)
    Table 53. Global Anti-inflammatory Biologics Sales Market Share by Type (2024-2029)
    Table 54. Global Anti-inflammatory Biologics Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Anti-inflammatory Biologics Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Anti-inflammatory Biologics Revenue Market Share by Type (2018-2023)
    Table 57. Global Anti-inflammatory Biologics Revenue Market Share by Type (2024-2029)
    Table 58. Global Anti-inflammatory Biologics Price (USD/MT) by Type (2018-2023)
    Table 59. Global Anti-inflammatory Biologics Price (USD/MT) by Type (2024-2029)
    Table 60. Global Anti-inflammatory Biologics Sales (K MT) by Application (2018-2023)
    Table 61. Global Anti-inflammatory Biologics Sales (K MT) by Application (2024-2029)
    Table 62. Global Anti-inflammatory Biologics Sales Market Share by Application (2018-2023)
    Table 63. Global Anti-inflammatory Biologics Sales Market Share by Application (2024-2029)
    Table 64. Global Anti-inflammatory Biologics Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Anti-inflammatory Biologics Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Anti-inflammatory Biologics Revenue Market Share by Application (2018-2023)
    Table 67. Global Anti-inflammatory Biologics Revenue Market Share by Application (2024-2029)
    Table 68. Global Anti-inflammatory Biologics Price (USD/MT) by Application (2018-2023)
    Table 69. Global Anti-inflammatory Biologics Price (USD/MT) by Application (2024-2029)
    Table 70. AbbVie Corporation Information
    Table 71. AbbVie Description and Business Overview
    Table 72. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 73. AbbVie Anti-inflammatory Biologics Product
    Table 74. AbbVie Recent Developments/Updates
    Table 75. Johnson & Johnson Corporation Information
    Table 76. Johnson & Johnson Description and Business Overview
    Table 77. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 78. Johnson & Johnson Anti-inflammatory Biologics Product
    Table 79. Johnson & Johnson Recent Developments/Updates
    Table 80. Amgen Inc Corporation Information
    Table 81. Amgen Inc Description and Business Overview
    Table 82. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 83. Amgen Inc Anti-inflammatory Biologics Product
    Table 84. Amgen Inc Recent Developments/Updates
    Table 85. AstraZeneca PLC Corporation Information
    Table 86. AstraZeneca PLC Description and Business Overview
    Table 87. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 88. AstraZeneca PLC Anti-inflammatory Biologics Product
    Table 89. AstraZeneca PLC Recent Developments/Updates
    Table 90. Pfizer, Inc Corporation Information
    Table 91. Pfizer, Inc Description and Business Overview
    Table 92. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 93. Pfizer, Inc Anti-inflammatory Biologics Product
    Table 94. Pfizer, Inc Recent Developments/Updates
    Table 95. Novartis Corporation Information
    Table 96. Novartis Description and Business Overview
    Table 97. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 98. Novartis Anti-inflammatory Biologics Product
    Table 99. Novartis Recent Developments/Updates
    Table 100. Roche Corporation Information
    Table 101. Roche Description and Business Overview
    Table 102. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 103. Roche Anti-inflammatory Biologics Product
    Table 104. Roche Recent Developments/Updates
    Table 105. Sun Pharmaceutical Industries Ltd Corporation Information
    Table 106. Sun Pharmaceutical Industries Ltd Description and Business Overview
    Table 107. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 108. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product
    Table 109. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Business Overview
    Table 112. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 113. Sanofi Anti-inflammatory Biologics Product
    Table 114. Sanofi Recent Developments/Updates
    Table 115. GlaxoSmithKline Corporation Information
    Table 116. GlaxoSmithKline Description and Business Overview
    Table 117. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 118. GlaxoSmithKline Anti-inflammatory Biologics Product
    Table 119. GlaxoSmithKline Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Anti-inflammatory Biologics Distributors List
    Table 123. Anti-inflammatory Biologics Customers List
    Table 124. Anti-inflammatory Biologics Market Trends
    Table 125. Anti-inflammatory Biologics Market Drivers
    Table 126. Anti-inflammatory Biologics Market Challenges
    Table 127. Anti-inflammatory Biologics Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anti-inflammatory Biologics
    Figure 2. Global Anti-inflammatory Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Anti-inflammatory Biologics Market Share by Type in 2022 & 2029
    Figure 4. Synthetic Type Product Picture
    Figure 5. Biological Type Product Picture
    Figure 6. Global Anti-inflammatory Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Anti-inflammatory Biologics Market Share by Application in 2022 & 2029
    Figure 8. Arthritis
    Figure 9. Respiratory Diseases
    Figure 10. Dermatology
    Figure 11. Gastroenterology
    Figure 12. Others
    Figure 13. Global Anti-inflammatory Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Anti-inflammatory Biologics Market Size (2018-2029) & (US$ Million)
    Figure 15. Global Anti-inflammatory Biologics Sales (2018-2029) & (K MT)
    Figure 16. Global Anti-inflammatory Biologics Average Price (USD/MT) & (2018-2029)
    Figure 17. Anti-inflammatory Biologics Report Years Considered
    Figure 18. Anti-inflammatory Biologics Sales Share by Manufacturers in 2022
    Figure 19. Global Anti-inflammatory Biologics Revenue Share by Manufacturers in 2022
    Figure 20. The Global 5 and 10 Largest Anti-inflammatory Biologics Players: Market Share by Revenue in 2022
    Figure 21. Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 22. Global Anti-inflammatory Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 23. North America Anti-inflammatory Biologics Sales Market Share by Country (2018-2029)
    Figure 24. North America Anti-inflammatory Biologics Revenue Market Share by Country (2018-2029)
    Figure 25. U.S. Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Canada Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Europe Anti-inflammatory Biologics Sales Market Share by Country (2018-2029)
    Figure 28. Europe Anti-inflammatory Biologics Revenue Market Share by Country (2018-2029)
    Figure 29. Germany Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. France Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. U.K. Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Italy Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Russia Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region (2018-2029)
    Figure 35. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region (2018-2029)
    Figure 36. China Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Japan Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. South Korea Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. India Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Australia Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Taiwan Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Indonesia Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Thailand Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Malaysia Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Philippines Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Latin America Anti-inflammatory Biologics Sales Market Share by Country (2018-2029)
    Figure 47. Latin America Anti-inflammatory Biologics Revenue Market Share by Country (2018-2029)
    Figure 48. Mexico Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Argentina Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Anti-inflammatory Biologics Sales Market Share by Country (2018-2029)
    Figure 52. Middle East & Africa Anti-inflammatory Biologics Revenue Market Share by Country (2018-2029)
    Figure 53. Turkey Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. U.A.E Anti-inflammatory Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Global Sales Market Share of Anti-inflammatory Biologics by Type (2018-2029)
    Figure 57. Global Revenue Market Share of Anti-inflammatory Biologics by Type (2018-2029)
    Figure 58. Global Anti-inflammatory Biologics Price (USD/MT) by Type (2018-2029)
    Figure 59. Global Sales Market Share of Anti-inflammatory Biologics by Application (2018-2029)
    Figure 60. Global Revenue Market Share of Anti-inflammatory Biologics by Application (2018-2029)
    Figure 61. Global Anti-inflammatory Biologics Price (USD/MT) by Application (2018-2029)
    Figure 62. Anti-inflammatory Biologics Value Chain
    Figure 63. Anti-inflammatory Biologics Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline
Frequently Asked Questions
Anti-inflammatory Biologics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-inflammatory Biologics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-inflammatory Biologics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Zero Client

This report aims to provide a comprehensive presentation of the global market for Zero Client, wi ... Read More